Key Findings

This is a quick summary of the main discovery for each research paper we have published, organized issue by issue. Each key finding is below the article title, with a link to the abstract. 


Search key findings View Previous Lists


Current List - September 2022

Affected other interventions: a systematic review and meta-analysis across addictions

Beneficial but mixed findings for effectiveness of interventions for people affected by another’s problematic alcohol/drug use and gambling.

Link to Abstract

Age-based differences in quantity and frequency of consumption when screening for harmful alcohol use

AUDIT items weakly associated with dependent or harmful drinking in younger and older drinkers have the strongest influence on their overall AUDIT scores

Link to Abstract

Common and distinguishing genetic factors for substance use behavior and disorder: an integrated analysis of genomic and transcriptomic studies from both human and animal studies

Systematic review identifies the shared and unique genes and pathways for alcohol, nicotine, and drug use behaviors and disorders

Link to Abstract

Economic evaluations of tobacco control interventions in low- and middle-income countries: a systematic review

There are few high-quality studies of the cost-effectiveness of tobacco use control interventions in LAMI countries.

Link to Abstract

Growing alcohol use preceding death by suicide among women compared with men: age-specific temporal trends, 2003–18

In the US between 2003 and 2018, alcohol use preceding death by suicide increased among women compared with men

Link to Abstract

Identifying prospective subpopulations of combustible and electronic cigarette dual users in the United States via finite mixture modeling

Dual users of combustible and e-cigarettes have eight well-defined prospective subpopulations

Link to Abstract

Insights from biosurveillance: non-fatal opioid overdoses in Rhode Island 2019–21

Fentanyl appears to be the main driver of the opioids overdose epidemic in Rhode Island, USA

Link to Abstract

Population-level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost-effectiveness analysis

Initiation of medications for opioid use disorder among detox inpatients would be cost-effective and could prevent overdoses

Link to Abstract

Prevalence of use and real-world effectiveness of smoking cessation aids during the COVID-19 pandemic: a representative study of smokers in England

In England, the Covid-19 pandemic was associated with increased use of remote support for smoking cessation and varenicline in quit attempts

Link to Abstract

Recurrent risk of hospitalization among older people with problematic alcohol use: a multiple failure-time analysis with a discontinuous risk model

Older addiction service users in Sweden have varying risks of hospitalization due to alcohol use, polydrug use and psychiatric disorders

Link to Abstract

Smoking prevalence following the announcement of tobacco tax increases in England between 2007 and 2019: an interrupted time–series analysis

Announcements of higher cigarette tax in England associated with temporary reductions in smoking prevalence/per capita cigarette consumption and improved quit success

Link to Abstract

The characteristics of people who inject drugs in the United Kingdom: changes in age, duration, and incidence of injecting, 1980–2019, using evidence from repeated cross-sectional surveys

The population of PWID in the UK has an older average age and longer average injecting history than in previous decades

Link to Abstract

The opioid use disorder core outcomes set (OUD–COS) for treatment research: findings from a Delphi consensus study

A Delphi consensus study has produced the NIDA CTN opioid use disorder core outcomes set for OUD treatment research

Link to Abstract